Humacyte (HUMA) Profit After Tax Growth (1y) (2021 - 2026)
Humacyte (HUMA) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Humacyte |
267.09 Mn |
218.55 Mn |
-1.54 Mn |
-145.02% |
| Date | Value |
|---|
| Mar 31, 2026 |
-145.02% |
| Dec 31, 2025 |
-18.45% |
| Sep 30, 2025 |
55.33% |
| Jun 30, 2025 |
33.54% |
| Mar 31, 2025 |
222.71% |
| Dec 31, 2024 |
16.59% |
| Sep 30, 2024 |
-50.81% |
| Jun 30, 2024 |
-149.55% |
| Mar 31, 2024 |
13.72% |
| Dec 31, 2023 |
-574.89% |
| Sep 30, 2023 |
-2.82% |
| Jun 30, 2023 |
-161.59% |
| Mar 31, 2023 |
-86.41% |
| Dec 31, 2022 |
-108.74% |
| Sep 30, 2022 |
19.90% |
| Jun 30, 2022 |
314.37% |
| Mar 31, 2022 |
2.31% |
| Dec 31, 2021 |
2,899.69% |
| Sep 30, 2021 |
-76,973.16% |
